Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J S Cross

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Lancet. Digital Health|February 26, 2022
Detection of all-cause advanced hepatic fibrosis using an ensemble machine learning frameworkTimothy J S Cross
Hepatology (Baltimore, Md.)|September 10, 2014
Diabetes, dyslipidemia, and death from hepatocellular carcinoma in the middle-aged and elderlyTimothy J S Cross
Clinical Medicine (London, England)|May 17, 2012
Offering HIV testing in an acute medical admissions unit in Newcastle upon TyneNicholas Thomas, Timothy J S Cross
Journal of Hepatology|January 1, 2016
Surveillance for hepatocellular carcinoma: A tale of two countriesCatriona Farrell, Timothy J S Cross
Gastroenterology & Hepatology|June 8, 2012
Amyloidosis and subacute liver failureMoby Joseph, Timothy J S Cross
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 5, 2010
Reply: outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapyDinesh Jothimani, Timothy J S Cross
Journal of Hepatology|July 9, 2021
Before we can find an evidence base for HCC surveillance, we need to define our target demographicCharmaine Matthews, Timothy J S Cross
BMJ (Clinical Research Ed.)|January 16, 2007
Chronic hepatitis CKosh Agarwal, Timothy J S Cross, Charles Gore
The New England Journal of Medicine|July 6, 2007
Viral hepatitis in HIV infectionTimothy J S Cross, Chris B Taylor, Philip M Harrison
The New England Journal of Medicine|March 21, 2008
Infection in solid-organ transplant recipientsTimothy J S Cross, Phillip A Berry, Andrew K Burroughs
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Lancet. Digital Health|February 26, 2022
Detection of all-cause advanced hepatic fibrosis using an ensemble machine learning frameworkTimothy J S Cross
Hepatology (Baltimore, Md.)|September 10, 2014
Diabetes, dyslipidemia, and death from hepatocellular carcinoma in the middle-aged and elderlyTimothy J S Cross
Clinical Medicine (London, England)|May 17, 2012
Offering HIV testing in an acute medical admissions unit in Newcastle upon TyneNicholas Thomas, Timothy J S Cross
Journal of Hepatology|January 1, 2016
Surveillance for hepatocellular carcinoma: A tale of two countriesCatriona Farrell, Timothy J S Cross
Gastroenterology & Hepatology|June 8, 2012
Amyloidosis and subacute liver failureMoby Joseph, Timothy J S Cross
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 5, 2010
Reply: outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapyDinesh Jothimani, Timothy J S Cross
Journal of Hepatology|July 9, 2021
Before we can find an evidence base for HCC surveillance, we need to define our target demographicCharmaine Matthews, Timothy J S Cross
BMJ (Clinical Research Ed.)|January 16, 2007
Chronic hepatitis CKosh Agarwal, Timothy J S Cross, Charles Gore
The New England Journal of Medicine|July 6, 2007
Viral hepatitis in HIV infectionTimothy J S Cross, Chris B Taylor, Philip M Harrison
The New England Journal of Medicine|March 21, 2008
Infection in solid-organ transplant recipientsTimothy J S Cross, Phillip A Berry, Andrew K Burroughs
Pageof 3